Community Acquired Pneumonia: Diagnosis and Treatment During the COVID-19 Era


Title: Community Acquired Pneumonia: Diagnosis and Treatment During the COVID-19 Era

Date: Tuesday, January 26

Time: 1 p.m. ET

Presenters: Antonio Anzueto, MD
Norman Moore, PhD

Co-sponsored by Abbott


Urinary Antigen Testing as a Diagnostic Alternative

This PACE-accredited webinar focuses on community acquired pneumonia (CAP) and two important pathogens that cause pneumonia. S. pneumonia is the leading cause of CAP. Legionella causes Legionnaires’ disease, a severe form of pneumonia that has increased nine-fold since the year 2000 in the United States. In light of COVID-19-related temporary shutdowns of businesses and buildings, the risk of growth and spread of Legionella is of heightened concern.

In the laboratory, urinary antigen testing (UAT) provides an alternate diagnostic path to identify pneumonia etiologies without disrupting respiratory testing workflows during respiratory season. The practical utility of pneumonia diagnosis as well as the use and impact of UAT will be addressed.

Join this expert discussion to explore the challenges of managing pneumonia during the COVID-19 era and the value of UAT from an evidence-based and IDSA/ATS guidelines-supported assessment for clinical and laboratory professionals.

Learning Objectives

This webinar will help you:

  • Describe the relationship between COVID-19 and pneumonia and the associated public health risks
  • Share experiences and best practices for evaluating and managing COVID-19 patients with pneumonia
  • Explain the guidance and practical clinical value of UAT, including mortality reduction and antibiotic stewardship
  • Discuss UAT performance characteristics and the potential value to laboratories in times of strained respiratory testing resources

Watch on Demand       Download Slides (PDF, 3MB)

For research use only. Not for diagnostic procedures.

This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E.™ Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.



Antonio R. Anzueto, MD

Dr. Antonio R. Anzueto is chief of the pulmonary section of the South Texas Veterans Health Care System, Audie L. Murphy Memorial Veterans Hospital Division in San Antonio, Texas, where he also serves as medical director of the Respiratory Therapy Department and the Pulmonary Function Laboratory. He is also a professor in the Department of Medicine at the University of Texas Health Science Center at San Antonio.

Anzueto received his medical degree from the Universidad de San Carlos de Guatemala in Guatemala City, Guatemala. He served his residency at the University of Texas Health Science Center at San Antonio, where he also completed a fellowship in critical care medicine and pulmonary diseases.

Anzueto currently serves on the editorial board of the American Journal of Respiratory and Critical Care Medicine, American College of CHEST Physicians Journal, the COPD Journal, and the Respiratory Research Journal. He is affiliated with several professional organizations, such as the Texas Thoracic Society, the American Thoracic Society, and the Global Initiative for Chronic Obstructive Lung Disease (GOLD). Anzueto has published over 300 manuscripts in highly rated medical journals. He has also received multiple awards such as Teacher of the Year from the University of Texas, Health Science Center at San Antonio.


Norman Moore, PhD

Dr. Norman Moore is director of infectious disease and scientific affairs for Abbott Rapid Diagnostics.